Name (Synonyms) | Correlation | |
---|---|---|
drug2837 | Technology-assisted Index Wiki | 0.58 |
drug2506 | SARSCoV2 Convalescent Plasma Wiki | 0.58 |
There are 3 clinical trials
The objective of this study is to develop and evaluate an algorithm which accurately predicts mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.
Description: Deceased or not deceased
Measure: Mortality outcome in COVID-19 ICU patients Time: Through study completion, an average of 2 monthsDescription: Deceased or not deceased
Measure: Mortality outcome in mechanically ventilated ICU patients Time: Through study completion, an average of 2 monthsDescription: Deceased or not deceased
Measure: Mortality outcome in pneumonia ICU patients Time: Through study completion, an average of 2 monthsThe purpose of this study is to prospectively evaluate a machine learning algorithm for the prediction of outcomes in COVID-19 patients.
Description: Ventilated or not ventilated within 24 hours
Measure: Mechanically ventilated patient outcome Time: Through study completion, an average of 2 monthsDescription: Death or ventilated, or no death or not ventilated within 24 hours
Measure: Mortality or mechanically ventilated patient outcome Time: Through study completion, an average of 2 monthsThe purpose of this study was to assess the performance of a machine learning algorithm which identifies patients for whom hydroxychloroquine treatment is associated with predicted survival.
Description: Time to in-hospital death
Measure: Mortality outcome Time: Through study completion, an average of 3 months